Oligonucleotidic sequences able to silence the expression of the CYCLIN D1-TROP2 chimera and uses thereof in medical field (United States Patent)
Brevetto
Data di Pubblicazione:
2009
Abstract:
The invention concerns RNA oligonucleotide sequences or sequences that are transcribed into RNA or analogous molecules able to silence the expression of the CYCLINDl/TROP2 chimeric mRNA and their use in the treatment and the prevention of tumors.
Tipologia CRIS:
6.1 Brevetto
Keywords:
TROP2, Cyclin D1, chimeric mRNA, siRNA, anticancer therapy
Elenco autori:
Guerra, Emanuela; Alberti, Saverio
Link alla scheda completa: